Literature DB >> 35754589

COVID toes following vaccination.

Annia Cavazos1, Anasua Deb1, Upama Sharma1, Kenneth Nugent1.   

Abstract

Cutaneous manifestations of COVID-19 infections include "COVID toes." These are pernio-like, pale purple, painful, ill-defined cyanotic lesions that have inflammatory infiltrates on histologic studies. COVID toes can also develop following COVID vaccination. COVID toes was reported by 29 individuals to the Vaccine Adverse Event Reporting System maintained by the Centers for Disease Control and Prevention through May 25, 2021. The mean age of these individuals was 52 ± 18 years; 23 (79%) were women. They had received both mRNA vaccines and the adenovirus vector-based vaccine. This discoloration developed 4.5 ± 9.8 days following vaccination, usually after the first dose. Four individuals required hospitalization for systemic symptoms, and one died. This information indicates that some individuals develop important clinical syndromes following vaccination and suggests that some of the manifestations of COVID-19 infection represent immune responses and not necessarily active tissue infection.
Copyright © 2022 Baylor University Medical Center.

Entities:  

Keywords:  COVID toes; COVID-19 vaccination; vaccine adverse events

Year:  2022        PMID: 35754589      PMCID: PMC9196769          DOI: 10.1080/08998280.2022.2043732

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  20 in total

1.  Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines.

Authors:  Johanna Chapin-Bardales; Julianne Gee; Tanya Myers
Journal:  JAMA       Date:  2021-06-01       Impact factor: 56.272

2.  The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries.

Authors:  Esther E Freeman; Devon E McMahon; Jules B Lipoff; Misha Rosenbach; Carrie Kovarik; Seemal R Desai; Joanna Harp; Junko Takeshita; Lars E French; Henry W Lim; Bruce H Thiers; George J Hruza; Lindy P Fox
Journal:  J Am Acad Dermatol       Date:  2020-07-02       Impact factor: 11.527

3.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

4.  Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.

Authors:  Devon E McMahon; Erin Amerson; Misha Rosenbach; Jules B Lipoff; Danna Moustafa; Anisha Tyagi; Seemal R Desai; Lars E French; Henry W Lim; Bruce H Thiers; George J Hruza; Kimberly G Blumenthal; Lindy P Fox; Esther E Freeman
Journal:  J Am Acad Dermatol       Date:  2021-04-07       Impact factor: 11.527

Review 5.  Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.

Authors:  John G Rizk; Aashish Gupta; Partha Sardar; Brandon Michael Henry; John C Lewin; Giuseppe Lippi; Carl J Lavie
Journal:  JAMA Cardiol       Date:  2021-12-01       Impact factor: 14.676

Review 6.  Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.

Authors:  A V Marzano; N Cassano; G Genovese; C Moltrasio; G A Vena
Journal:  Br J Dermatol       Date:  2020-07-05       Impact factor: 11.113

7.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

8.  Cutaneous manifestations in COVID-19: Lessons learned from current evidence.

Authors:  Poonkiat Suchonwanit; Kanchana Leerunyakul; Chaninan Kositkuljorn
Journal:  J Am Acad Dermatol       Date:  2020-04-24       Impact factor: 11.527

9.  'Blue toes' following vaccination with the BNT162b2 mRNA COVID-19 vaccine.

Authors:  Benjamin Davido; Helene Mascitti; Marc Fortier-Beaulieu; Karim Jaffal; Pierre de Truchis
Journal:  J Travel Med       Date:  2021-06-01       Impact factor: 8.490

Review 10.  Myocarditis With COVID-19 mRNA Vaccines.

Authors:  Biykem Bozkurt; Ishan Kamat; Peter J Hotez
Journal:  Circulation       Date:  2021-07-20       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.